185 related articles for article (PubMed ID: 10809224)
1. Malignant rhabdoid tumor: A phenotype? An entity?--A controversy revisited.
Ogino S; Ro TY; Redline RW
Adv Anat Pathol; 2000 May; 7(3):181-90. PubMed ID: 10809224
[TBL] [Abstract][Full Text] [Related]
2. Establishment of a cell line from a malignant rhabdoid tumor of the liver lacking the function of two tumor suppressor genes, hSNF5/INI1 and p16.
Kuroda H; Moritake H; Sawada K; Kuwahara Y; Imoto I; Inazawa J; Sugimoto T
Cancer Genet Cytogenet; 2005 Apr; 158(2):172-9. PubMed ID: 15796965
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis of hSNF5/INI1 distinguishes renal and extra-renal malignant rhabdoid tumors from other pediatric soft tissue tumors.
Hoot AC; Russo P; Judkins AR; Perlman EJ; Biegel JA
Am J Surg Pathol; 2004 Nov; 28(11):1485-91. PubMed ID: 15489652
[TBL] [Abstract][Full Text] [Related]
4. Pathology and diagnosis of SMARCB1-deficient tumors.
Margol AS; Judkins AR
Cancer Genet; 2014 Sep; 207(9):358-64. PubMed ID: 25246033
[TBL] [Abstract][Full Text] [Related]
5. Chromosome 22q dosage in composite extrarenal rhabdoid tumors: clonal evolution or a phenotypic mimic?
Fuller CE; Pfeifer J; Humphrey P; Bruch LA; Dehner LP; Perry A
Hum Pathol; 2001 Oct; 32(10):1102-8. PubMed ID: 11679945
[TBL] [Abstract][Full Text] [Related]
6. Cerebral rhabdomyosarcoma with rhabdoid tumor-like features.
Caputo V; Repetti ML; Grimoldi N; Lazzarini G; Masini B; Radice F
J Neurooncol; 1997 Mar; 32(1):81-6. PubMed ID: 9049866
[TBL] [Abstract][Full Text] [Related]
7. [A malignant rhabdoid tumor appearing simultaneously in the kidney and the brain of an infant: case report].
Morizane A; Nakahara I; Takahashi JA; Ishikawa M; Kikuchi H
No Shinkei Geka; 1997 Jul; 25(7):665-9. PubMed ID: 9218263
[TBL] [Abstract][Full Text] [Related]
8. Mutations of the p53 gene in malignant rhabdoid tumors of soft tissue and the kidney: immunohistochemical and DNA direct sequencing analysis.
Kinoshita Y; Shiratsuchi H; Tamiya S; Oshiro Y; Hachitanda Y; Oda Y; Suita S; Tsuneyoshi M
J Cancer Res Clin Oncol; 2001; 127(6):351-8. PubMed ID: 11414195
[TBL] [Abstract][Full Text] [Related]
9. Malignant rhabdoid tumor of the kidney in a child: report of a case with recurrence in the contralateral kidney.
Cocker RS; Sharaan M; Wasserman P
Acta Cytol; 2004; 48(6):836-42. PubMed ID: 15581170
[TBL] [Abstract][Full Text] [Related]
10. Cytokeratin subunits of inclusion bodies in rhabdoid cells: immunohistochemical and clinicopathological study of malignant rhabdoid tumor and epithelioid sarcoma.
Shiratsuchi H; Oshiro Y; Saito T; Itakura E; Kinoshita Y; Tamiya S; Oda Y; Komiyama S; Tsuneyoshi M
Int J Surg Pathol; 2001 Jan; 9(1):37-48. PubMed ID: 11469343
[TBL] [Abstract][Full Text] [Related]
11. Aberrations of the hSNF5/INI1 gene are restricted to malignant rhabdoid tumors or atypical teratoid/rhabdoid tumors in pediatric solid tumors.
Uno K; Takita J; Yokomori K; Tanaka Y; Ohta S; Shimada H; Gilles FH; Sugita K; Abe S; Sako M; Hashizume K; Hayashi Y
Genes Chromosomes Cancer; 2002 May; 34(1):33-41. PubMed ID: 11921280
[TBL] [Abstract][Full Text] [Related]
12. SMARCB1-deficient Tumors of Childhood: A Practical Guide.
Pawel BR
Pediatr Dev Pathol; 2018; 21(1):6-28. PubMed ID: 29280680
[TBL] [Abstract][Full Text] [Related]
13. Congenital disseminated malignant rhabdoid tumor: a distinct clinicopathologic entity demonstrating abnormalities of chromosome 22q11.
White FV; Dehner LP; Belchis DA; Conard K; Davis MM; Stocker JT; Zuppan CW; Biegel JA; Perlman EJ
Am J Surg Pathol; 1999 Mar; 23(3):249-56. PubMed ID: 10078913
[TBL] [Abstract][Full Text] [Related]
14. Extrarenal rhabdoid tumors of soft tissue: clinicopathological and molecular genetic review and distinction from other soft-tissue sarcomas with rhabdoid features.
Oda Y; Tsuneyoshi M
Pathol Int; 2006 Jun; 56(6):287-95. PubMed ID: 16704491
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical study as a tool in differential diagnosis of pediatric malignant rhabdoid tumor.
Machado I; Noguera R; Santonja N; Donat J; Fernandez-Delgado R; Acevedo A; Baragaño M; Navarro S
Appl Immunohistochem Mol Morphol; 2010 Mar; 18(2):150-8. PubMed ID: 19770707
[TBL] [Abstract][Full Text] [Related]
16. Malignant rhabdoid tumors: a clinicopathologic review and conceptual discussion.
Wick MR; Ritter JH; Dehner LP
Semin Diagn Pathol; 1995 Aug; 12(3):233-48. PubMed ID: 8545590
[TBL] [Abstract][Full Text] [Related]
17. Malignant rhabdoid tumor of the liver. A distinct clinicopathologic entity.
Hunt SJ; Anderson WD
Am J Clin Pathol; 1990 Nov; 94(5):645-8. PubMed ID: 1700599
[TBL] [Abstract][Full Text] [Related]
18. hSNF5/INI1-deficient tumours and rhabdoid tumours are convergent but not fully overlapping entities.
Bourdeaut F; Fréneaux P; Thuille B; Lellouch-Tubiana A; Nicolas A; Couturier J; Pierron G; Sainte-Rose C; Bergeron C; Bouvier R; Rialland X; Laurence V; Michon J; Sastre-Garau X; Delattre O
J Pathol; 2007 Feb; 211(3):323-30. PubMed ID: 17152049
[TBL] [Abstract][Full Text] [Related]
19. Subcellular distribution of cytokeratin and vimentin in malignant rhabdoid tumor: three-dimensional imaging with confocal laser scanning microscopy and double immunofluorescence.
Itakura E; Tamiya S; Morita K; Shiratsuchi H; Kinoshita Y; Oshiro Y; Oda Y; Ohta S; Furue M; Tsuneyoshi M
Mod Pathol; 2001 Sep; 14(9):854-61. PubMed ID: 11557780
[TBL] [Abstract][Full Text] [Related]
20. SMARCB1/INI1 missense mutation in mucinous carcinoma with rhabdoid features.
Cho YM; Choi J; Lee OJ; Lee HI; Han DJ; Ro JY
Pathol Int; 2006 Nov; 56(11):702-6. PubMed ID: 17040295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
